BioSpace News Archive

HuidaGene Therapeutics (辉大基因; HuidaGene), a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, Alvin Luk, Ph.D., M.B.A., C.C.R.A., as Co-Founder, Member of the Board of Directors, and Chief Executive Officer.

AbCellera (Nasdaq: ABCL) today announced a CA$701 million co-investment with the Governments of Canada and British Columbia to build new capabilities and infrastructure to develop innovative antibody-based medicines and strengthen Canada’s leadership in clinical research, manufacturing, and drug development.

Pluton Biosciences, a startup leveraging the power of microbes to create cost-effective innovative solutions that address sustainability challenges facing agriculture, announces the close of a $16.5 M Series A funding round.

Scientists at Klick Labs have developed a new way to catch the earliest signs the human body is failing to control blood glucose levels, before it reaches prediabetic levels in patients.

Reveal Lasers LLC, a leading provider of energy-based devices, is proud to announce today the launch of Eterna - an FDA-cleared radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables.

Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced it will be participating in the following investor conferences.

Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that management will participate in the following investor conferences.

Ocuphire Pharma, Inc., announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved an equity award under Ocuphire’s Inducement Plan, as a material inducement to a new hire in connection with such new hire’s employment with the Company effective on May 22, 2023.

Relay Therapeutics, Inc. announced that management will participate in two upcoming fireside chats.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the addition of Folate Receptor Alpha to its Precise™ Oncology Solutions portfolio.